t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with cyclosporine in 2 studies
| Studies (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Trials (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Recent Studies (post-2010) (t-butyloxycarbonyl-methionyl-leucyl-phenylalanine) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccarelli, A; Cirillo, R; de Crescenzo, G; de Paulis, A; Marone, G; Patella, V | 1 |
| Bylund, J; Dahlgren, C; Fu, H; Karlsson, J; Stenfeldt, AL; Wennerås, C | 1 |
2 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and cyclosporine
| Article | Year |
|---|---|
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
Topics: Basophils; Binding, Competitive; Bryostatins; Chemokine CCL2; Chemokine CCL5; Complement C5a; Cyclosporine; Histamine Release; Humans; Interleukin-1; Interleukin-8; Kinetics; Lactones; Leukotriene C4; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Platelet Activating Factor; Protein Binding; Tetradecanoylphorbol Acetate | 1996 |
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.
Topics: Complement C5a; Cyclosporine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oligopeptides; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Time Factors | 2007 |